| Corrie Lamoreaux Stapleton, NP | |
|
1112 E 300 N Ste 202, American Fork, UT 84003-2484 | |
| (801) 577-7055 | |
| Not Available |
| Full Name | Corrie Lamoreaux Stapleton |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 1112 E 300 N Ste 202, American Fork, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225796451 | NPI | - | NPPES |
| 10832313-8900 | Other | UT | APRN CONTROLLED SUBSTANCE SCHEDULE 2-5 LICENSE |
| 10832313-4405 | Other | UT | STATE APRN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 10832313-4405 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Option Care Infusion Suites Llc | 5698179125 | 5 |
| Premier Family Medical | 7416197785 | 71 |
News Archive
A high prevalence of depression among older individuals with dementia is prompting researchers at the University of Arizona College of Pharmacy and Banner Alzheimer's Institute to investigate depression treatment among this population.
In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular disease, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Researchers in the U.S. say a new drug effectively treats serious cases of gout - the drug called pegloticase mimics a blood-clearing enzyme missing in humans and helps remove the build up in uric acid, which causes the painful, needle-like crystals to collect around fingers, toes and other joints.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the completion of a clinical study with the company's PaQ Insulin Delivery Device.
› Verified 7 days ago
| Entity Name | Premier Family Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750725735 PECOS PAC ID: 7416197785 Enrollment ID: O20130710000079 |
News Archive
A high prevalence of depression among older individuals with dementia is prompting researchers at the University of Arizona College of Pharmacy and Banner Alzheimer's Institute to investigate depression treatment among this population.
In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular disease, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Researchers in the U.S. say a new drug effectively treats serious cases of gout - the drug called pegloticase mimics a blood-clearing enzyme missing in humans and helps remove the build up in uric acid, which causes the painful, needle-like crystals to collect around fingers, toes and other joints.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the completion of a clinical study with the company's PaQ Insulin Delivery Device.
› Verified 7 days ago
| Entity Name | Option Care Infusion Suites Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164194601 PECOS PAC ID: 5698179125 Enrollment ID: O20211122002842 |
News Archive
A high prevalence of depression among older individuals with dementia is prompting researchers at the University of Arizona College of Pharmacy and Banner Alzheimer's Institute to investigate depression treatment among this population.
In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular disease, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Researchers in the U.S. say a new drug effectively treats serious cases of gout - the drug called pegloticase mimics a blood-clearing enzyme missing in humans and helps remove the build up in uric acid, which causes the painful, needle-like crystals to collect around fingers, toes and other joints.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the completion of a clinical study with the company's PaQ Insulin Delivery Device.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Corrie Lamoreaux Stapleton, NP 1112 E 300 N Ste 202, American Fork, UT 84003-2484 Ph: (801) 577-7055 | Corrie Lamoreaux Stapleton, NP 1112 E 300 N Ste 202, American Fork, UT 84003-2484 Ph: (801) 577-7055 |
News Archive
A high prevalence of depression among older individuals with dementia is prompting researchers at the University of Arizona College of Pharmacy and Banner Alzheimer's Institute to investigate depression treatment among this population.
In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular disease, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Researchers in the U.S. say a new drug effectively treats serious cases of gout - the drug called pegloticase mimics a blood-clearing enzyme missing in humans and helps remove the build up in uric acid, which causes the painful, needle-like crystals to collect around fingers, toes and other joints.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the completion of a clinical study with the company's PaQ Insulin Delivery Device.
› Verified 7 days ago
Andrew Olesen, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 922 Nob Hill Ave, American Fork, UT 84003 Phone: 801-471-0951 | |
Sandra Burkinshaw, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1248 E 90 N, Suite 300, American Fork, UT 84003 Phone: 801-756-9635 | |
Sarah Prentice, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 226 N 1100 E, American Fork, UT 84003 Phone: 801-855-3841 | |
Joseph Woodruff Palmer, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1175 E 50 S Ste 171, American Fork, UT 84003 Phone: 801-772-0698 Fax: 801-772-0705 | |
Mr. Orrin Blake Hansen, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 241, American Fork, UT 84003 Phone: 801-492-5999 Fax: 801-418-0897 | |
Hayley Alece Jolley, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1248 E 90 N Ste 103, American Fork, UT 84003 Phone: 801-852-9560 | |
Mr. Todd L Chidester, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1159 E 200 N Suite 200, American Fork, UT 84003 Phone: 801-756-5290 Fax: 801-756-5200 |